Dr Reddy#39;s recalls all its ranitidine products in US

The city-based drug maker said in a filing with bourses that the recall, which began on October 1, is at the retail level for Over-The-Counter products and at the consumer level for prescription products of all of its ranitidine medications sold in US due to confirmed contamination with N-Nitrosodimethylamine (NDMA) above levels established by FDA.

from Moneycontrol Business News https://ift.tt/35XbAmP